Found 9803 related files. Current in page 1
Image interpretation is related with the identification of remote sensed objects or images and knowing about their significance. To see the useful result of image interpretation the primary tasks are Detection, Identification, Measurement, Problem solving.
Perhaps the dominance of EDI over Internet-based e-procurement in the manufacturing sector accounts for this result. Other studies that examine Swedish firms find that access to broadband is associated with increases in productivity of 3.6 percent for manufacturing and services firms
The Finnish study mentioned above finds that granting an employee Internet access at work increases his productivity by three percent in the service sector, but has no significant effect in manufacturing
It is also possible to be qualified and approved for mortgage loans online at BEA. Again, the Bank claims that processing is fully automatic: human intervention is required only when loan documents are signed at the branch
Holden binder describes four primary benefits about how to choose high quality custom binders to improve your business. For more information call 800-715-9255
English is a widely spoken language of the world. Almost 70 countries in the world use English as an official language. This language finds an important place in school instruction, online communication and business transactions.
Department of Research and Development, Hospira Inc., Lake Forest, Illinois, USA, 2Department of Medical Ethics, University of Pennsylvania, Philadelphia, Pennsylvania, USA, 3Advanced Centre for Biochemical Engineering, University College London, London, UK, 4The Stop ALD Foundation, Houston, Texas, USA, 5Interdisciplinary Oncology Program, H. Lee Mofﬁtt Cancer Center & Research Institute, Tampa, Florida, USA, 6Department of Regulatory Affairs, Perkin Elmer Inc., Cambridge, Massachusetts, USA, 7Bone Marrow Transplantation Unit, National Cancer Institute, Rio de Janeiro, Brazil, 8Section of Hematology and Bone Marrow Transplantation Unit, University Hospital, Cremona, Italy, 9Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, 10Department of Cell and Molecular Therapies, Royal Prince Alfred Hospital RPA Hospital and Centenary Institute, Newtown, NSW Australia, 11Research Foundation for , Community Medicine, Tokyo, Japan, and 12Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA Key Words: cell therapy, stem cell, medical tourism, medical ethics, informed consent, regulatory affairs
Perspective Cardiac Stem Cell Therapy and the Promise of Heart Regeneration Jessica C. Garbern1 and Richard T. Lee2,* 1Department of Medicine, Boston Children’s Hospital, Boston, MA 02115, USA Stem Cell Institute, the Brigham Regenerative Medicine Center and the Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA *Correspondence: email@example.com http://dx.doi.org/10.1016/j.stem.2013.05.008 2Harvard Stem cell therapy for cardiac disease is an exciting but highly controversial research area. Strategies such as cell transplantation and reprogramming have demonstrated both intriguing and sobering results. Yet as clinical trials proceed, our incomplete understanding of stem cell behavior is made evident by numerous unresolved matters, such as the mechanisms of cardiomyocyte turnover or the optimal therapeutic strategies to achieve clinical efﬁcacy. In this Perspective, we consider how cardiac stem cell biology has led us into clinical trials, and we suggest that achieving true cardiac regeneration in patients may ultimately require resolution of critical controversies in experimental cardiac regeneration. Introduction The race is on: throughout the world, basic and clinical investigators want to be the ﬁrst to identify new approaches to regenerate cardiac tissue and to prove the effects of these therapies in patients with heart disease. Despite substantial progress in treating many types of heart disease, the worldwide heart failure burden will remain enormous through this century. The potential of stem cells and the scope of the heart failure problem have fueled a stampede to be the ﬁrst to achieve human heart regeneration. Cell transplantation approaches are attractive given their...
Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for the Treatment of Diabetic Foot Ulcers Grafix closes three times as many wounds as standard of care - the largest relative improvement ever reported in a multi-center, randomized, controlled clinical trial for DFU COLUMBIA, Md. - August 13,2013 - Osiris Therapeutics, Inc. (NASDAQ: OSIR), reported today that its multicenter, randomized, controlled clinical trial comparing the safety and effectiveness of Grafix® to standard of care in patients with chronic diabetic foot ulcers had met the pre-specified stopping rules for overwhelming efficacy as determined by the data monitoring committee during a planned interim analysis. For the primary endpoint, 62% of patients receiving Grafix had complete wound closure compared to only 21% (p<0.0001) of patients who received conventional treatment for their wounds - a relative improvement of 191% and the largest ever reported from such a study. A total of 131 patients were enrolled with the interim analysis being conducted on the first 97 to complete the trial. The trial also reached statistical significance in favor of Grafix on all top-line secondary endpoints, demonstrating faster wound closure and a reduction in the number of treatments needed to achieve wound closure. In the crossover phase of the trial, patients whose wounds failed to close after 12 weeks of standard of care had an 80% closure rate when switched to Grafix. Importantly, patients randomized to receive standard of care were 74% more likely to experience an adverse event than those receiving Grafix (p=0.008). As a result, the blinded phase of the trial is being discontinued immediately and all patients randomized to the control arm will be offered treatment with Grafix. “Today, Osiris has established a new standard in diabetic wound care and has demonstrated to the world the tremendous impact stem cell products can have in medicine,” said C. Randal Mills, Ph.D., Chief Executive Officer. “Diabetic foot ulcers afflict 25% of all diabetics and are responsible for more hospitalizations than any other diabetic complication. With 25 million diabetics in the United States, the cost to our health care system is enormous. Through this rigorous study we have shown that Grafix can heal more patients, in less time, and with fewer complications.”
QUALIFYING LOCATIONS: Qualifying Products (as defined below) must be purchased from the U.S. Apple Online Store for Education Individuals, from a U.S. Apple Retail Store, by calling 1-800-MY-APPLE, or from an Apple Authorized Campus Store on the list at www.apple.com/promo/bts/participants.html (collectively, “Qualifying Locations”). iPhone devices must be purchased from Apple; Apple Authorized Campus Store iPhone purchases are not eligible. Only purchases made in the 50 United States or the District of Columbia are eligible. All shipments of Qualifying Products must be made to an address in the 50 United States or the District of Columbia. Orders for Qualifying Products from the U.S. Apple Online Store for Education Individuals or 1-800-MY-APPLE that are placed during the above promotion period and ship after the offer ends are eligible. EDUCATION INDIVIDUAL PURCHASE QUALIFICATIONS: Those eligible to purchase as Education Individuals include faculty, staff, students, and parents as follows: K–12: Any employee of a public or private K–12 institution in the United States is eligible. In addition, school board members who are currently serving as elected or appointed members are eligible. PTA or PTO executives currently serving as elected or appointed officers are eligible. Higher Education: Faculty and staff of higher education institutions; and students attending or accepted into a higher education institution are eligible. Higher Education Parents: Parents purchasing on behalf of their child, who is a student currently attending or accepted into a public or private higher education institution in the United States, are eligible. PRODUCT ELIGIBILITY: Only the following Apple products qualify for this promotion: Qualifying Apple Computers: iMac, MacBook Pro, MacBook Air, and Mac Pro. Qualifying iPhone: iPhone 4, iPhone 4S, and iPhone 5.